The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Year: 2011
Type: article
Abstract: OBJECTIVE: Most smoking cessation studies have used long-term abstinence as their primary outcome measure. Recent research has suggested that long-term abstinence may be an insensitive index of important smoking cessation mechanisms. The goal of the current study was to examine the effects of 5 smoking cessation pharmacotherapies using Shiffman et al.'s (2006) approach of examining the effect of smoking cessation medications on 3 process markers of cessation or smoking cessation milestones: initial abstinence, lapse, and the lapse-relapse transition. METHOD: The current study (N = 1,504; 58.2% female and 41.8% male; 83.9% Caucasian, 13.6% African American, 2.5% other races) examined the effect of 5 smoking cessation pharmacotherapy treatments versus placebo (bupropion, nicotine lozenge, nicotine patch, bupropion + lozenge, patch + lozenge) on Shiffman et al.'s smoking cessation milestones over 8 weeks following a quit attempt. RESULTS: Results show that all 5 medication conditions decreased rates of failure to achieve initial abstinence and most (with the exception of the nicotine lozenge) decreased lapse risk; however, only the nicotine patch and bupropion + lozenge conditions affected the lapse-relapse transition. CONCLUSIONS: These findings demonstrate that medications are effective at aiding initial abstinence and decreasing lapse risk but that they generally do not decrease relapse risk following a lapse. The analysis of cessation milestones sheds light on important impediments to long-term smoking abstinence, suggests potential mechanisms of action of smoking cessation pharmacotherapies, and identifies targets for future treatment development.
DOI: 10.1037/a0022154
Authors: Sandra J. Japuntich, Megan E. Piper, Adam M. Leventhal, Daniel M. Bolt, Timothy B. Baker
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1867228831, Training in Translational Tobacco Science, G2546782160, General Clinical Research Center, Institutional Clinical and Translational Science Award (UW-Madison)(UL1), Institutional Clinical and Translational Science Award (UW-Madison), G5750085034, Affective and Genetic Correlates of Amphetamine Response, G6303374422, G6372020884, Mechanisms Linking Anhedonia and Tobacco Addiction, Tobacco Dependence: Treatment and Outcomes, G9000159662, G9000186323, G9000224832, G95697253
OpenAlex ID: W2148602515
